United States· US:67877-506_6289ed62-26fb-4c9e-971a-39a5e53c5c2e

Colesevelam HCL

A colesevelam product containing colesevelam hcl, registered in United States by Ascend Laboratories, LLC. The same ATC class is registered in 14 of our 19 countries.

ATC C10AC04Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedColesevelam HCLATCC10AC04REGISTER NO.US:67877-506_6289ed62…PACKS LISTED4CHECKEDSeptember 12, 2026

Where it is registered

Colesevelam is registered in 14 of 19 countries.

Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Colesevelam · ATC C10AC04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of colesevelam costs, country by country.

Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.

  • United States: $1.57 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Colesevelam · price per daily dose (3.75 g)

USD · FX 28 Sept 2026

  • ES Spain$5.96
  • US United States$1.57 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Colesevelam HCL
Manufacturer
Ascend Laboratories, LLC
Country
United States (US)
ATC code
C10AC04
ATC class
Colesevelam
Defined daily dose
3.75 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 4

  • ndc11
    6787750605
    500 TABLET, FILM COATED in 1 BOTTLE (67877-506-05)
  • ndc11
    6787750630
    30 TABLET, FILM COATED in 1 BOTTLE (67877-506-30)
  • ndc11
    6787750651
    180 TABLET, FILM COATED in 1 BOTTLE (67877-506-51)
  • ndc11
    6787750690
    90 TABLET, FILM COATED in 1 BOTTLE (67877-506-90)

Regulatory notes

UNII (FDA substance ID)
P4SG24WI5Q
COLESEVELAM HYDROCHLORIDE
RxCUI 141625
Orange Book
A209038
AB
DailyMed SPL labels
1 version tracked

Interactions

63 interactions on record for colesevelam.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colesevelam · interactions on record

63 records

  • 5 severe
  • 58 moderate

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colesevelam in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colesevelam products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Colesevelamhydrochlorid Ascend
  • United Kingdom (Northern Ireland) · Colesevelam Hydrochloride Consilient Health, Colesevelam Hydrochloride Dr. Reddy's Laboratories (Uk)
  • Iceland · Cholestagel
  • Liechtenstein · Cholestagel
  • Norway · Cholestagel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c54eeba2-a04b-4af1-a0a6-f99d8c8db033
GET /v1/drugs/c54eeba2-a04b-4af1-a0a6-f99d8c8db033?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "P4SG24WI5Q",
    "rxcui": "141625",
    "inchikey": null,
    "display_name": "COLESEVELAM HYDROCHLORIDE",
    "substance_type": "polymer",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "dbed6967-b261-44a1-bee4-638810e2efe9": {
      "match": "brand_token",
      "title": "COLESEVELAM HYDROCHLORIDE POWDER, FOR SUSPENSION [BRYANT RANCH PREPACK]",
      "spl_version": "103",
      "published_date": "2026-05-28"
    }
  },
  "productid": "67877-506_6289ed62-26fb-4c9e-971a-39a5e53c5c2e",
  "productndc": "67877-506",
  "dosage_form": "TABLET, FILM COATED",
  "orange_book": {
    "appl_no": "209038",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "625MG",
        "product_no": "001",
        "approval_date": "Oct 5, 2018"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "COLESEVELAM HYDROCHLORIDE",
  "proprietary_name": "Colesevelam HCL",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA209038",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Colesevelam HCL",
  "start_marketing_date": "20181006",
  "active_numerator_strength": "625"
}

See everything about colesevelam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.